GWAS Based on RNA-Seq Snps and High-Throughput Phenotyping
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Interpreting Noncoding Genetic Variation in Complex Traits and Human Disease
REVIEW Interpreting noncoding genetic variation in complex traits and human disease Lucas D Ward1,2 & Manolis Kellis1,2 Association studies provide genome-wide information about the genetic basis of complex disease, but medical research has focused primarily on protein-coding variants, owing to the difficulty of interpreting noncoding mutations. This picture has changed with advances in the systematic annotation of functional noncoding elements. Evolutionary conservation, functional genomics, chromatin state, sequence motifs and molecular quantitative trait loci all provide complementary information about the function of noncoding sequences. These functional maps can help with prioritizing variants on risk haplotypes, filtering mutations encountered in the clinic and performing systems-level analyses to reveal processes underlying disease associations. Advances in predictive modeling can enable data-set integration to reveal pathways shared across loci and alleles, and richer regulatory models can guide the search for epistatic interactions. Lastly, new massively parallel reporter experiments can systematically validate regulatory predictions. Ultimately, advances in regulatory and systems genomics can help unleash the value of whole-genome sequencing for personalized genomic risk assessment, diagnosis and treatment. Understanding the genetic basis of disease can transform medicine ture of the human genome, and its systematic mapping by the HapMap by elucidating relevant biochemical pathways for drug targets and by Project9, allowed single-nucleotide polymorphisms (SNPs) to be used enabling personalized risk assessments1,2. With the evolution of technol- as markers for common haplotypes, which could be genotyped using ogies over the past century, geneticists are no longer limited to studying chip technology. The stage was set for a flood of unbiased, genome-wide Mendelian disorders and can tackle complex phenotypes. -
Multiple Cellular Proteins Interact with LEDGF/P75 Through a Conserved Unstructured Consensus Motif
ARTICLE Received 19 Jan 2015 | Accepted 1 Jul 2015 | Published 6 Aug 2015 DOI: 10.1038/ncomms8968 Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif Petr Tesina1,2,3,*, Katerˇina Cˇerma´kova´4,*, Magdalena Horˇejsˇ´ı3, Katerˇina Procha´zkova´1, Milan Fa´bry3, Subhalakshmi Sharma4, Frauke Christ4, Jonas Demeulemeester4, Zeger Debyser4, Jan De Rijck4,**, Va´clav Veverka1,** & Pavlı´na Rˇeza´cˇova´1,3,** Lens epithelium-derived growth factor (LEDGF/p75) is an epigenetic reader and attractive therapeutic target involved in HIV integration and the development of mixed lineage leukaemia (MLL1) fusion-driven leukaemia. Besides HIV integrase and the MLL1-menin complex, LEDGF/p75 interacts with various cellular proteins via its integrase binding domain (IBD). Here we present structural characterization of IBD interactions with transcriptional repressor JPO2 and domesticated transposase PogZ, and show that the PogZ interaction is nearly identical to the interaction of LEDGF/p75 with MLL1. The interaction with the IBD is maintained by an intrinsically disordered IBD-binding motif (IBM) common to all known cellular partners of LEDGF/p75. In addition, based on IBM conservation, we identify and validate IWS1 as a novel LEDGF/p75 interaction partner. Our results also reveal how HIV integrase efficiently displaces cellular binding partners from LEDGF/p75. Finally, the similar binding modes of LEDGF/p75 interaction partners represent a new challenge for the development of selective interaction inhibitors. 1 Institute of Organic Chemistry and Biochemistry of the ASCR, v.v.i., Flemingovo nam. 2, 166 10 Prague, Czech Republic. 2 Department of Genetics and Microbiology, Faculty of Science, Charles University in Prague, Vinicna 5, 128 44 Prague, Czech Republic. -
Genetics in Harry Potter's World: Lesson 2
Genetics in Harry Potter’s World Lesson 2 • Beyond Mendelian Inheritance • Genetics of Magical Ability 1 Rules of Inheritance • Some traits follow the simple rules of Mendelian inheritance of dominant and recessive genes. • Complex traits follow different patterns of inheritance that may involve multiples genes and other factors. For example, – Incomplete or blended dominance – Codominance – Multiple alleles – Regulatory genes Any guesses on what these terms may mean? 2 Incomplete Dominance • Incomplete dominance results in a phenotype that is a blend of a heterozygous allele pair. Ex., Red flower + Blue flower => Purple flower • If the dragons in Harry Potter have fire-power alleles F (strong fire) and F’ (no fire) that follow incomplete dominance, what are the phenotypes for the following dragon-fire genotypes? – FF – FF’ – F’F’ 3 Incomplete Dominance • Incomplete dominance results in a phenotype that is a blend of the two traits in an allele pair. Ex., Red flower + Blue flower => Purple flower • If the Dragons in Harry Potter have fire-power alleles F (strong fire) and F’ (no fire) that follow incomplete dominance, what are the phenotypes for the following dragon-fire genotypes: Genotypes Phenotypes FF strong fire FF’ moderate fire (blended trait) F’F’ no fire 4 Codominance • Codominance results in a phenotype that shows both traits of an allele pair. Ex., Red flower + White flower => Red & White spotted flower • If merpeople have tail color alleles B (blue) and G (green) that follow the codominance inheritance rule, what are possible genotypes and phenotypes? Genotypes Phenotypes 5 Codominance • Codominance results in a phenotype that shows both traits of an allele pair. -
The Genetics of Complex Traits Programme Course 7.5 Credits Genetiska Mekanismer Bakom Komplexa Egenskaper 8MEA14 Valid From: 2019 Autumn Semester
DNR LIU-2019-00662 1(5) The genetics of complex traits Programme course 7.5 credits Genetiska mekanismer bakom komplexa egenskaper 8MEA14 Valid from: 2019 Autumn semester Determined by The Board for First and Second Cycle Programmes at the Faculty of Medicine and Health Sciences Date determined 2019-03-07 LINKÖPING UNIVERSITY FACULTY OF MEDICINE AND HEALTH SCIENCES LINKÖPING UNIVERSITY THE GENETICS OF COMPLEX TRAITS FACULTY OF MEDICINE AND HEALTH SCIENCES 2(5) Main field of study Medical Biology Course level Second cycle Advancement level A1X Course offered for Master's Programme in Experimental and Medical Biosciences Entry requirements Degree of Bachelor of Science, 180 ECTS in a major subject area such as medicine, biology, technology/natural sciences, odontology or veterinary medicine. 90 ECTS of courses included in the Bachelor degree should be in subjects such as biochemistry, cell biology, molecular biology, genetics, gene technology, microbiology, immunology, physiology, histology, anatomy or pathology. Documented skills in English corresponding to level 6/B. Intended learning outcomes The student will learn and understand the basis of quantitative genetic techniques, in particular how they pertain to the identification of genes underlying complex traits and diseases. Knowledge and understanding On completion of the course, the student shall be able to: Describe and understand statistical quantitative genetic techniques and how they apply to complex traits. Explain the statistical basis of quantitative traits. Explain and distinguish between linkage and linkage disequilibrium and their uses. Analyse the genetic architecture of different behavioral and disease-related traits. Analyse and understand the theory and steps required to identify the genetic components of a quantitative trait. -
The Function and Evolution of C2H2 Zinc Finger Proteins and Transposons
The function and evolution of C2H2 zinc finger proteins and transposons by Laura Francesca Campitelli A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Molecular Genetics University of Toronto © Copyright by Laura Francesca Campitelli 2020 The function and evolution of C2H2 zinc finger proteins and transposons Laura Francesca Campitelli Doctor of Philosophy Department of Molecular Genetics University of Toronto 2020 Abstract Transcription factors (TFs) confer specificity to transcriptional regulation by binding specific DNA sequences and ultimately affecting the ability of RNA polymerase to transcribe a locus. The C2H2 zinc finger proteins (C2H2 ZFPs) are a TF class with the unique ability to diversify their DNA-binding specificities in a short evolutionary time. C2H2 ZFPs comprise the largest class of TFs in Mammalian genomes, including nearly half of all Human TFs (747/1,639). Positive selection on the DNA-binding specificities of C2H2 ZFPs is explained by an evolutionary arms race with endogenous retroelements (EREs; copy-and-paste transposable elements), where the C2H2 ZFPs containing a KRAB repressor domain (KZFPs; 344/747 Human C2H2 ZFPs) are thought to diversify to bind new EREs and repress deleterious transposition events. However, evidence of the gain and loss of KZFP binding sites on the ERE sequence is sparse due to poor resolution of ERE sequence evolution, despite the recent publication of binding preferences for 242/344 Human KZFPs. The goal of my doctoral work has been to characterize the Human C2H2 ZFPs, with specific interest in their evolutionary history, functional diversity, and coevolution with LINE EREs. -
A Collection of Pre-Mrna Splicing Mutants in Arabidopsis Thaliana
G3: Genes|Genomes|Genetics Early Online, published on April 7, 2020 as doi:10.1534/g3.119.400998 1 1 A collection of pre-mRNA splicing mutants in Arabidopsis thaliana 2 3 4 Tatsuo Kanno1,a, Peter Venhuizen2,a, Ming-Tsung Wu3, Phebe Chiou1, Chia-Liang Chang1, 5 Maria Kalyna2,c, Antonius J.M. Matzke1,c and Marjori Matzke1,c 6 7 1Institute of Plant and Microbial Biology, Academia Sinica, 128, Sec. 2, Academia Rd., Nangang 8 District, Taipei, 11529 Taiwan 9 10 2Department of Applied Genetics and Cell Biology, University of Natural Resources and Life 11 Sciences - BOKU, Muthgasse 18, 1190 Vienna, Austria 12 13 3Department of Plant Sciences, University of Cambridge, Downing Street, CB2 3EA Cambridge, 14 UK 15 16 athese authors should be regarded as joint first authors 17 18 19 cCorresponding authors: 20 Antonius J.M. Matzke ([email protected]) 21 Tel: +886-2787-1135 22 Marjori Matzke ([email protected]) 23 Tel: +886-2787-1135 24 Maria Kalyna ([email protected]) 25 Tel: +43-1-47654-94112 26 27 28 29 30 31 32 © The Author(s) 2020. Published by the Genetics Society of America. 2 33 34 Running title: Arabidopsis pre-mRNA splicing mutants 35 36 Key words: Arabidopsis thaliana, CBP80. miRNAs, mutant screen, pre-mRNA splicing 37 38 39 40 Corresponding authors: 41 Antonius J.M. Matzke ([email protected]), Institute of Plant and Microbial 42 Biology, Academia Sinica, 128, Sec. 2, Academia Rd., Nangang District, Taipei, 11529 Taiwan 43 Tel: +886-2787-1135 44 45 Marjori Matzke ([email protected]), Institute of Plant and Microbial Biology, 46 Academia Sinica, 128, Sec. -
IWS1 Antibody A
Revision 1 C 0 2 - t IWS1 Antibody a e r o t S Orders: 877-616-CELL (2355) [email protected] Support: 877-678-TECH (8324) 1 8 Web: [email protected] 6 www.cellsignal.com 5 # 3 Trask Lane Danvers Massachusetts 01923 USA For Research Use Only. Not For Use In Diagnostic Procedures. Applications: Reactivity: Sensitivity: MW (kDa): Source: UniProt ID: Entrez-Gene Id: WB, IP, IF-IC H M R Endogenous 140 Rabbit Q96ST2 55677 Product Usage Information Application Dilution Western Blotting 1:1000 Immunoprecipitation 1:50 Immunofluorescence (Immunocytochemistry) 1:200 Storage Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody. Specificity / Sensitivity IWS1 Antibody detects endogenous levels of total IWS1 protein. Species Reactivity: Human, Mouse, Rat Source / Purification Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human IWS1 protein. Antibodies are purified by protein A and peptide affinity chromatography. Background Various steps in gene expression, such as mRNA processing, surveillance, export, and synthesis are coupled to transcription elongation (1,2). The C-terminal domain (CTD) of the large subunit of RNA polymerase II plays an important role in the integration of these different steps (1,2). IWS1 interacts with Spt6, a CTD-binding transcription elongation factor and H3 chaperone (1,2). IWS1 also recruits another CTD-binding protein, HYPB/Setd2 histone methyltransferase, to the RNA polymerase II complex for elongation-coupled H3K36 trimethylation (2). Thus, IWS1 links Spt6 and HYPB/Setd2 in a large complex and regulates mRNA synthesis and histone methylation at the co- transcriptional level (2). -
Genetic Analysis of Complex Traits in the Emerging Collaborative Cross
Downloaded from genome.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press Research Genetic analysis of complex traits in the emerging Collaborative Cross David L. Aylor,1 William Valdar,1,13 Wendy Foulds-Mathes,1,13 Ryan J. Buus,1,13 Ricardo A. Verdugo,2,13 Ralph S. Baric,3,4 Martin T. Ferris,1 Jeff A. Frelinger,4 Mark Heise,1 Matt B. Frieman,4 Lisa E. Gralinski,4 Timothy A. Bell,1 John D. Didion,1 Kunjie Hua,1 Derrick L. Nehrenberg,1 Christine L. Powell,1 Jill Steigerwalt,5 Yuying Xie,1 Samir N.P. Kelada,6 Francis S. Collins,6 Ivana V. Yang,7 David A. Schwartz,7 Lisa A. Branstetter,8 Elissa J. Chesler,2 Darla R. Miller,1 Jason Spence,1 Eric Yi Liu,9 Leonard McMillan,9 Abhishek Sarkar,9 Jeremy Wang,9 Wei Wang,9 Qi Zhang,9 Karl W. Broman,10 Ron Korstanje,2 Caroline Durrant,11 Richard Mott,11 Fuad A. Iraqi,12 Daniel Pomp,1,14 David Threadgill,5,14 Fernando Pardo-Manuel de Villena,1,14 and Gary A. Churchill2,14 1Department of Genetics, University of North Carolina–Chapel Hill, Chapel Hill, North Carolina 27599, USA; 2The Jackson Laboratory, Bar Harbor, Maine 04609, USA; 3Department of Epidemiology, University of North Carolina–Chapel Hill, Chapel Hill, North Carolina 27599, USA; 4Department of Microbiology and Immunology, University of North Carolina–Chapel Hill, Chapel Hill, North Carolina 27599, USA; 5Department of Genetics, North Carolina State University, Raleigh, North Carolina 27695, USA; 6Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland -
Dynamics of Transcription-Dependent H3k36me3 Marking by the SETD2:IWS1:SPT6 Ternary Complex
bioRxiv preprint doi: https://doi.org/10.1101/636084; this version posted May 14, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Dynamics of transcription-dependent H3K36me3 marking by the SETD2:IWS1:SPT6 ternary complex Katerina Cermakova1, Eric A. Smith1, Vaclav Veverka2, H. Courtney Hodges1,3,4,* 1 Department of Molecular & Cellular Biology, Center for Precision Environmental Health, and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA 2 Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic 3 Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA 4 Department of Bioengineering, Rice University, Houston, TX, 77005, USA * Lead contact; Correspondence to: [email protected] Abstract The genome-wide distribution of H3K36me3 is maintained SETD2 contributes to gene expression by marking gene through various mechanisms. In human cells, H3K36 is bodies with H3K36me3, which is thought to assist in the mono- and di-methylated by eight distinct histone concentration of transcription machinery at the small portion methyltransferases; however, the predominant writer of the of the coding genome. Despite extensive genome-wide data trimethyl mark on H3K36 is SETD21,11,12. Interestingly, revealing the precise localization of H3K36me3 over gene SETD2 is a major tumor suppressor in clear cell renal cell bodies, the physical basis for the accumulation, carcinoma13, breast cancer14, bladder cancer15, and acute maintenance, and sharp borders of H3K36me3 over these lymphoblastic leukemias16–18. In these settings, mutations sites remains rudimentary. -
A Master Autoantigen-Ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases
bioRxiv preprint doi: https://doi.org/10.1101/2021.07.30.454526; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases Julia Y. Wang1*, Michael W. Roehrl1, Victor B. Roehrl1, and Michael H. Roehrl2* 1 Curandis, New York, USA 2 Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA * Correspondence: [email protected] or [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.07.30.454526; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Chronic and debilitating autoimmune sequelae pose a grave concern for the post-COVID-19 pandemic era. Based on our discovery that the glycosaminoglycan dermatan sulfate (DS) displays peculiar affinity to apoptotic cells and autoantigens (autoAgs) and that DS-autoAg complexes cooperatively stimulate autoreactive B1 cell responses, we compiled a database of 751 candidate autoAgs from six human cell types. At least 657 of these have been found to be affected by SARS-CoV-2 infection based on currently available multi-omic COVID data, and at least 400 are confirmed targets of autoantibodies in a wide array of autoimmune diseases and cancer. -
Reference Trait Analysis Reveals Correlations Between Gene Expression and Quantitative Traits in Disjoint Samples
HIGHLIGHTED ARTICLE | INVESTIGATION Reference Trait Analysis Reveals Correlations Between Gene Expression and Quantitative Traits in Disjoint Samples Daniel A. Skelly,* Narayanan Raghupathy,* Raymond F. Robledo,* Joel H. Graber,*,† and Elissa J. Chesler*,1 *The Jackson Laboratory, Bar Harbor, Maine 04609 and †MDI Biological Laboratory, Bar Harbor, Maine 04609 ORCID IDs: 0000-0002-2329-2216 (D.A.S.); 0000-0002-5642-5062 (E.J.C.) ABSTRACT Systems genetic analysis of complex traits involves the integrated analysis of genetic, genomic, and disease-related measures. However, these data are often collected separately across multiple study populations, rendering direct correlation of molecular features to complex traits impossible. Recent transcriptome-wide association studies (TWAS) have harnessed gene expression quantitative trait loci (eQTL) to associate unmeasured gene expression with a complex trait in genotyped individuals, but this approach relies primarily on strong eQTL. We propose a simple and powerful alternative strategy for correlating independently obtained sets of complex traits and molecular features. In contrast to TWAS, our approach gains precision by correlating complex traits through a common set of continuous phenotypes instead of genetic predictors, and can identify transcript–trait correlations for which the regulation is not genetic. In our approach, a set of multiple quantitative “reference” traits is measured across all individuals, while measures of the complex trait of interest and transcriptional profiles are obtained in disjoint subsamples. A conventional multivariate statistical method, canonical correlation analysis, is used to relate the reference traits and traits of interest to identify gene expression correlates. We evaluate power and sample size requirements of this methodology, as well as performance relative to other methods, via extensive simulation and analysis of a behavioral genetics experiment in 258 Diversity Outbred mice involving two independent sets of anxiety-related behaviors and hippocampal gene expression. -
Genetics and Human Traits
Help Me Understand Genetics Genetics and Human Traits Reprinted from MedlinePlus Genetics U.S. National Library of Medicine National Institutes of Health Department of Health & Human Services Table of Contents 1 Are fingerprints determined by genetics? 1 2 Is eye color determined by genetics? 3 3 Is intelligence determined by genetics? 5 4 Is handedness determined by genetics? 7 5 Is the probability of having twins determined by genetics? 9 6 Is hair texture determined by genetics? 11 7 Is hair color determined by genetics? 13 8 Is height determined by genetics? 16 9 Are moles determined by genetics? 18 10 Are facial dimples determined by genetics? 20 11 Is athletic performance determined by genetics? 21 12 Is longevity determined by genetics? 23 13 Is temperament determined by genetics? 26 Reprinted from MedlinePlus Genetics (https://medlineplus.gov/genetics/) i Genetics and Human Traits 1 Are fingerprints determined by genetics? Each person’s fingerprints are unique, which is why they have long been used as a way to identify individuals. Surprisingly little is known about the factors that influence a person’s fingerprint patterns. Like many other complex traits, studies suggest that both genetic and environmental factors play a role. A person’s fingerprints are based on the patterns of skin ridges (called dermatoglyphs) on the pads of the fingers. These ridges are also present on the toes, the palms of the hands, and the soles of the feet. Although the basic whorl, arch, and loop patterns may be similar, the details of the patterns are specific to each individual. Dermatoglyphs develop before birth and remain the same throughout life.